| Judith A Dunipace, MD | |
|
1250 E County Line Rd, Suite 13, Indianapolis, IN 46227-1004 | |
| (317) 887-9999 | |
| (317) 883-0426 |
| Full Name | Judith A Dunipace |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 1250 E County Line Rd, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073575650 | NPI | - | NPPES |
| 200042150 | Medicaid | IN | |
| 000000493220 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | 01040468A (Indiana) | Primary |
| 207LP2900X | Anesthesiology - Pain Medicine | 01040468A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Major Hospital | Shelbyville, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Major Hospital | 0446167415 | 77 |
| Major Multispecialty Associates | 6305997842 | 44 |
News Archive
A new study finds an association between an increase in assisted living options, which provide older adults with an array of services such as help with everyday tasks in homelike settings, and a decline in nursing home occupancy. This shift in delivery of care has both positive and negative implications for seniors.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Novartis announced today that the US Food and Drug Administration has approved Signifor long-acting release (LAR) (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
› Verified 2 days ago
| Entity Name | Major Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174555692 PECOS PAC ID: 0446167415 Enrollment ID: O20040108000586 |
News Archive
A new study finds an association between an increase in assisted living options, which provide older adults with an array of services such as help with everyday tasks in homelike settings, and a decline in nursing home occupancy. This shift in delivery of care has both positive and negative implications for seniors.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Novartis announced today that the US Food and Drug Administration has approved Signifor long-acting release (LAR) (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
› Verified 2 days ago
| Entity Name | Johnson Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346248986 PECOS PAC ID: 8527972595 Enrollment ID: O20040316000585 |
News Archive
A new study finds an association between an increase in assisted living options, which provide older adults with an array of services such as help with everyday tasks in homelike settings, and a decline in nursing home occupancy. This shift in delivery of care has both positive and negative implications for seniors.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Novartis announced today that the US Food and Drug Administration has approved Signifor long-acting release (LAR) (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
› Verified 2 days ago
| Entity Name | Major Multispecialty Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437398492 PECOS PAC ID: 6305997842 Enrollment ID: O20090624000134 |
News Archive
A new study finds an association between an increase in assisted living options, which provide older adults with an array of services such as help with everyday tasks in homelike settings, and a decline in nursing home occupancy. This shift in delivery of care has both positive and negative implications for seniors.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Novartis announced today that the US Food and Drug Administration has approved Signifor long-acting release (LAR) (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Judith A Dunipace, MD Po Box 6069, Dept 212, Indianapolis, IN 46206-6069 Ph: (317) 887-9999 | Judith A Dunipace, MD 1250 E County Line Rd, Suite 13, Indianapolis, IN 46227-1004 Ph: (317) 887-9999 |
News Archive
A new study finds an association between an increase in assisted living options, which provide older adults with an array of services such as help with everyday tasks in homelike settings, and a decline in nursing home occupancy. This shift in delivery of care has both positive and negative implications for seniors.
Thoughtified Limited, a SETsquared start-up company created by graduates of the Department of Computing, University of Surrey has won a major grant from the Technology Strategy Board. The grant will enable the Surrey Research Park-based company to work in the development of a participatory sensing system that will improve the management of NHS patient records in remote patient treatment. The web and smartphone hybrid system will enable significant cost savings for the NHS, through improved utilisation of resources and reducing the inefficiencies that are typically incurred in the treatment of patients at home. The total finance raised for the project amounts to £94,000.
Researchers at Linköping University have made a discovery that could contribute to developing new vaccines and treatment alternatives for tuberculosis in the future. The results have been published in Scientific Reports, a sister journal to the highly respected periodical Nature.
Novartis announced today that the US Food and Drug Administration has approved Signifor long-acting release (LAR) (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
› Verified 2 days ago
Mr. David M Ratzman, M.D. Pain Medicine Medicare: May Accept Medicare Assignments Practice Location: 8240 Naad Rd, Ste 101, Indianapolis, IN 46260 Phone: 317-417-1400 Fax: 317-471-1900 | |
Michael Robert Dorwart, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd Rm 2180, Indianapolis, IN 46202 Phone: 317-274-0269 | |
Dr. Philip Michael Shumsky, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 West Michigan Street, Cl 626, Indianapolis, IN 46202 Phone: 317-278-2689 | |
Dr. John Joseph Fitzgerald, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 8805 N Meridian St, Indianapolis, IN 46260 Phone: 317-706-7246 Fax: 317-706-3417 | |
Dr. Daniel Diep Tran, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1481 W 10th St, Indianapolis, IN 46202 Phone: 317-318-6542 | |
Brian Hom, MD Pain Medicine Medicare: Medicare Enrolled Practice Location: 8805 N Meridian St, Indianapolis, IN 46260 Phone: 317-706-7246 |